Type of lung cancer-Non-small cell lung carcinoma (NSCLC) Page 2 Posts on Medivizor
Navigation Menu

Type of lung cancer-Non-small cell lung carcinoma (NSCLC) Posts on Medivizor

Searching for patients with non-small cell lung cancer suitable for surgery to test durvalumab with chemotherapy

Posted by on May 19, 2019 in Lung cancer | 0 comments

In a nutshell This phase 3 trial is examining the effectiveness of durvalumab (Imfinzi) combined with chemotherapy vs chemotherapy alone for stage II and III non-small cell lung cancer (NSCLC) before surgery. The main outcome to be measured will be the major pathological response (mPR; 10 percent or fewer alive cancer cells...

Read More

Is combined treatment with erlotinib and bevacizumab effective in non-small cell lung cancer?

Posted by on May 18, 2019 in Lung cancer | 0 comments

In a nutshell This study investigated the effectiveness of erlotinib (Tarceva) and bevacizumab (Avastin) compared ti erlotinib alone in non-small cell lung cancer (NSCLC). They found that combined treatment improved survival after 12 months. Some background Non-small cell lung cancer (NSCLC) is a common type of lung cancer (LC)....

Read More

Evaluating crizotinib for patients with non-small cell lung cancer that has spread to the brain

Posted by on May 4, 2019 in Lung cancer | 0 comments

In a nutshell This study evaluated how well crizotinib (Xalkori) works in patients with non-small cell lung cancer (NSCLC) with an ALK mutation that had spread to the brain. This study found that crizotinib treatment improved survival, but not for patients with cancer in the brain that continued to grow. Some background NSCLC is the most common type...

Read More

Looking for participants with advanced lung cancer to test a new cancer vaccine

Posted by on Mar 29, 2019 in Lung cancer | 0 comments

In a nutshell This trial is examining the effectiveness of a new cancer vaccine. The main outcomes to be measured are cancer response and side effects. This trial is recruiting in New York and Tennessee, US. The details The standard treatment for most cancers is surgery and chemotherapy. However, chemotherapy has a limited effectiveness and a high...

Read More

Searching for patients with advanced non-small cell lung cancer to trial a new treatment regime

Posted by on Mar 15, 2019 in Lung cancer | 0 comments

In a nutshell This trial aims to find out if combining nivolumab (Opdivo) and ipilimumab (Yervoy) with chemotherapy in patients with advanced non-small cell lung cancer is more effective than only treating with chemotherapy. The main outcome that will be measured is overall survival.  The details There are a number of different treatment options...

Read More

SBRT vs. radiotherapy in patients with inoperable non-small cell lung cancer

Posted by on Mar 5, 2019 in Lung cancer | 0 comments

In a nutshell This study determined whether stereotactic body radiation therapy (SBRT) was more effective than standard radiotherapy in patients with inoperable non-small cell lung cancer. The study found that SBRT led to better survival outcomes for these patients, with minimal side effects. Some background Tumor removal by surgery is the standard of...

Read More